Lipid Metabolism and Metabolic Syndrome Assessment

GeneLink’s Lipid Metabolism Assessment was designed to help predict an individual’s susceptibility to abnormalities related to lipid balance, lipid metabolism, functional areas that modulate blood pressure regulation and to Metabolic Syndrome.

Metabolic Syndrome is a serious emerging health problem that affects 40 to 50 million American adults. It is related to a constellation of abnormalities that include obesity, abnormal lipid metabolism, and insulin resistance that together yield enhanced risks of cardiovascular problems and Type 2 diabetes mellitus.

GeneLink’s Lipid Metabolism and Metabolic Syndrome Assessment is an important predictive tool for determining individual susceptibility to cardiovascular events and conditions related to this emerging health crisis.

Read more about Metabolic Syndrome